Maria-teresa M. Salcedo
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury.
Journal: Alimentary pharmacology & therapeutics
Published: October 16, 2023
Retreatment With Immune Checkpoint Inhibitors After a Severe Immune-Related Hepatitis: Results From a Prospective Multicenter Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 04, 2021
Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study.
Journal: World journal of gastroenterology
Published: February 16, 2021
Hepatic sinusoidal obstruction syndrome associated with nivolumab: an uncommon adverse event related to immune checkpoint inhibitors.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: November 08, 2020
Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: December 08, 2018
Decompensated Liver Disease due to Primary Hepatic Amyloidosis: Is Liver Transplantation Still Mandatory?
Journal: Hepatology (Baltimore, Md.)
Published: September 12, 2018
Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin.
Journal: Transfusion
Published: March 22, 2018
Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity.
Journal: Annals of hepatology
Published: May 16, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026